GlassScriptPhysician profile
Sandra A Thompson
NPI 1326085713
$57,661.32
in general payments reported to CMS, 2019-2025
47 companies · $16K in 2025
The $16K reported for 2025 was more than what 97% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,967 · 2020: $3,696 · 2021: $5,410 · 2022: $6,061 · 2023: $7,357 · 2024: $17K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Travel and Lodging: $12K · Education: $7,535 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,577 · Gift: $417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,008.55 |
| Travel and Lodging | $11,988.85 |
| Education | $7,535.32 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,577.00 |
| Gift | $417.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinefrontier, INC. | $16,276.78 | 2024-2025 | Nanofuse, Facetfuse, Inspan |
| Spinal Simplicity, LLC | $15,750.42 | 2021-2024 | Ha Minuteman G3-R |
| Abbott Laboratories | $6,679.79 | 2019-2025 | Proclaim, Octrode, Eterna |
| Medtronic, INC. | $6,539.80 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Vanta Adaptivestim |
| Medtronic USA, INC. | $2,600.95 | 2019-2020 | |
| Boston Scientific Corporation | $1,516.70 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Axiomed LLC | $1,351.49 | 2025 | Freedom Lumbar Disc |
| Spr Therapeutics, INC | $1,270.32 | 2021-2024 | Sprint Pns System |
| Nevro Corp. | $1,220.89 | 2020-2023 | Senza |
| Stimwave Technologies Incorporated | $653.00 | 2019-2022 | |
| Curonix LLC | $511.79 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Painteq LLC | $408.83 | 2022-2024 | Painteq |
| Collegium Pharmaceutical, INC. | $344.10 | 2019-2024 | Belbuca, Xtampza |
| Si-Bone, INC. | $297.94 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $270.34 | 2020-2024 | Ztlido |
Show all 46 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.